| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 18
| Issue : 3 | Page : 378-383 |
Application of da Vinci robot and laparoscopy on repeat hepatocellular carcinoma
Shuiping Yu1, Guandou Yuan1, Shiliu Lu1, Jiangfa Li2, Bo Tang1, Fudi Zhong1, Huizhao Su1, Songqin He1
1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
2 Department of Hepatobiliary Surgery, The Affiliated Hospital of Guilini Medical University, Guilin, Guangxi, China
Correspondence Address:
Songqin He
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jmas.JMAS_111_21
Background: Repeat laparoscopic liver resection has been used safely and effectively on hepatocellular carcinoma (HCC). However, few studies have been performed on repeat HCC surgery by a da Vinci robot. This study aims to evaluate the outcomes of the patients with repeat HCC treated using a da Vinci robot or laparoscopic system at a single centre.
Methods: All of the patients with repeat HCC treated using a da Vinci robotic or laparoscopic system between April 2017 and April 2020 were included in this retrospective study.
Results: There were 24 patients with a mean age of 56 years who underwent da Vinci robotic or laparoscopic surgery for treatment of repeat HCC who were included in this study. The operations lasted 152 ± 25 min and 142 ± 34 min. The average intraoperative blood loss was 284 ± 89 ml and 251 ± 92 ml. The average hospitalisation stay lasted 9 ± 2 days and 9 ± 3 days. The rates at which surgeons switched to open surgery were 9% and 23%. No serious perioperative or post-operative complications were encountered.
Conclusion: Da Vinci robots can provide a precise dissection of the tissue under a perfect view. It is a technically feasible procedure for less rates at which surgeons switched to open surgery on repeat HCC.
[FULL TEXT] [PDF]*
|
